Physician profile
Jon D Bush
NPI 1912940891
$754.19
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $367 · 2020: $62.80 · 2021: $32.56 · 2022: $160 · 2023: $51.43 · 2024: $80.02.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $131.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $131.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $153.32 | 2019-2023 | |
| Abbvie INC. | $110.98 | 2021-2023 | Teflaro |
| Abbott Laboratories | $83.52 | 2019 | |
| Janssen Pharmaceuticals, INC | $83.50 | 2019-2021 | |
| Outset Medical INC | $80.02 | 2024 | |
| Novartis Pharmaceuticals Corporation | $62.86 | 2019-2020 | |
| Allergan, INC. | $47.62 | 2019 | |
| Lilly USA, LLC | $31.83 | 2022 | |
| Merck Sharp & Dohme LLC | $28.23 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.43 | 2022 | |
| Mallinckrodt Enterprises LLC | $16.38 | 2019 | |
| Ferring Pharmaceuticals INC. | $14.23 | 2022 | |
| Vapotherm INC | $12.05 | 2019 | |
| Chiesi USA, INC. | $11.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Bush listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.